Jr. Michael Conick Hanley - May 20, 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
Chief Operating Officer
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
May 20, 2024
Transactions value $
$0
Form type
4
Date filed
5/22/2024, 05:19 PM
Previous filing
Feb 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Employee Stock Option (right to buy) Award $0 +188K $0.00 188K May 20, 2024 Common Stock 188K $12.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on May 20, 2025, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.